Your browser doesn't support javascript.
loading
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?
Tedeschi, Alessandra; Frustaci, Anna Maria; Mauro, Francesca Romana; Chiarenza, Annalisa; Coscia, Marta; Ciolli, Stefania; Reda, Gianluigi; Laurenti, Luca; Varettoni, Marzia; Murru, Roberta; Baratè, Claudia; Sportoletti, Paolo; Greco, Antonino; Borella, Chiara; Rossi, Valentina; Deodato, Marina; Biagi, Annalisa; Zamprogna, Giulia; Pelle, Angelo Curto; Lapietra, Gianfranco; Vitale, Candida; Morelli, Francesca; Cassin, Ramona; Fresa, Alberto; Cavalloni, Chiara; Postorino, Massimiliano; Ielo, Claudia; Cairoli, Roberto; Di Raimondo, Francesco; Montillo, Marco; Del Poeta, Giovanni.
Afiliación
  • Tedeschi A; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Frustaci AM; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Mauro FR; Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Rome, Italy.
  • Chiarenza A; Division of Hematology, AOU "Policlinico-Vittorio Emanuele," University of Catania, Catania, Italy.
  • Coscia M; Division of Hematology, AOU Città della Salute e della Scienza di Torino, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Ciolli S; Department of Hematology, Università degli Studi di Firenze, Firenze, Italy.
  • Reda G; Department of Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Laurenti L; Hematology Institute, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma, Italy.
  • Varettoni M; Division of Hematology Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Murru R; Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, ARNAS "G. Brotzu," Cagliari, Italy.
  • Baratè C; Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Sportoletti P; Division of Hematology and Clinical Immunology, Department of Medicine, University of Perugia, Perugia, Italy.
  • Greco A; Department of Hematology, Azienda Ospedaliera Giovanni Panìco, Tricase, Italy.
  • Borella C; Department of Hematology, Ospedale San Gerardo, Monza, Italy.
  • Rossi V; Hematology & Transfusion Medicine L. Sacco University Hospital and School of Medicine, Milano, Italy; and.
  • Deodato M; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Biagi A; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
  • Zamprogna G; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Pelle AC; Division of Hematology, AOU "Policlinico-Vittorio Emanuele," University of Catania, Catania, Italy.
  • Lapietra G; Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Rome, Italy.
  • Vitale C; Division of Hematology, AOU Città della Salute e della Scienza di Torino, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Morelli F; Department of Hematology, Università degli Studi di Firenze, Firenze, Italy.
  • Cassin R; Department of Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Fresa A; Hematology Institute, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma, Italy.
  • Cavalloni C; Division of Hematology Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Postorino M; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
  • Ielo C; Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Rome, Italy.
  • Cairoli R; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Di Raimondo F; Division of Hematology, AOU "Policlinico-Vittorio Emanuele," University of Catania, Catania, Italy.
  • Montillo M; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Del Poeta G; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
Blood Adv ; 5(24): 5490-5500, 2021 12 28.
Article en En | MEDLINE | ID: mdl-34525181
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Leucemia Linfocítica Crónica de Células B Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Leucemia Linfocítica Crónica de Células B Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article País de afiliación: Italia